muscular man. credit: Jaime Blanchart - pexels-blanxybuilding

Does Creatine Build Muscle Without Exercise?

A 12-week trial found creatine raised lean mass by about 1.1 kg (2.4 lb) without exercise — but the estimate was imprecise and exercise status self-selected.

In a 12-week randomized trial in 64 sedentary adults aged 45–65, creatine raised lean mass by about 1.1 kg without structured exercise and about 1.3 kg with exercise and diet — but the no-exercise estimate has a wide confidence interval, exercise status was self-selected rather than randomized, and the trial was industry-funded.

In a 12-week randomized, double-blind, placebo-controlled trial in 64 sedentary adults aged 45–65, 10 g/day of creatine monohydrate raised lean tissue mass by about 1.1 kg (2.4 lb) without structured exercise and by about 1.27 kg (2.8 lb) alongside a weight-loss diet and supervised exercise program, versus little change on placebo — but the no-exercise gain carries wide uncertainty, exercise status was self-selected rather than randomized, and the trial was industry-funded.

What this means

In a 12-week randomized, double-blind, placebo-controlled trial, 10 g/day of creatine monohydrate raised lean tissue mass by about 1.1 kg (2.4 lb) in sedentary middle-aged and older adults who did not start a structured exercise program, and by about 1.27 kg (2.8 lb) in those who paired it with a weight-loss diet and supervised exercise; the placebo groups barely changed. Two boundaries qualify that result: the no-exercise estimate is imprecise — its 95% confidence interval, a range of effects consistent with the data, spans 0.2 kg to 2.0 kg (about 0.4 to 4.4 lb) — and only the creatine-versus-placebo assignment was randomized, because whether a person exercised was self-selected. The trial was also funded with industry support, and its cognitive and blood-marker results are exploratory rather than confirmed benefits.

The claim, and the study behind it

On October 5, 2026, a wave of coverage summarized a new trial under headlines like “Creatine may help build muscle even without exercise.” The trial behind it is real, and its design is stronger than most supplement coverage: a 12-week randomized, double-blind, placebo-controlled, parallel-group study of creatine monohydrate at 10 g/day (two 5 g doses) against a maltodextrin placebo, in healthy sedentary adults aged 45–65 — peer-reviewed and published in August 2026. The headline, though, stops short of what the design can carry.

Two factors, only one randomized

The trial set out to test creatine in two settings at once: on its own, and alongside a weight-loss diet plus supervised exercise. Structurally that is a 2×2 comparison, but only one factor was randomized. Participants chose whether to join the exercise-and-diet program; within each self-selected stratum, the researchers matched people on age, height, body mass, BMI and sex, then assigned them in a counterbalanced way to creatine or placebo, both double-blind. Randomization, blinding and the placebo comparison therefore apply to the supplement, not to exercise. The no-exercise contrast — creatine against placebo among people who did not take up the program — is a genuine randomized, placebo-controlled test of creatine alone. A comparison of exercising against non-exercising participants is not.

Who took part

Seventy-three adults were randomized or consented, and 64 completed the 12 weeks and were analyzed: 40 women and 24 men. On average they were 54.5 years old, weighed 84.5 kg (186 lb), and had a body-mass index of about 29.9. They were healthy but sedentary. That is a middle-aged and older, overweight-on-average group — not a frail or clinical population, not people already training, and not a broad cross-section of adults. The non-exercise stratum held 26 participants and the exercise stratum 38, so the randomized creatine-versus-placebo contrast without exercise rests on the smaller group.

What the numbers show

By 12 weeks, the no-exercise creatine group had gained about 1.1 kg (2.4 lb) of lean tissue mass (95% CI 0.2 to 2.0 kg), significantly more than placebo. The exercise-plus-diet creatine group gained about 1.27 kg (2.8 lb; 95% CI 0.56 to 1.98 kg, or about 1.2 to 4.4 lb). The placebo groups barely moved: the exercise-plus-diet placebo arm changed by +0.14 kg (0.3 lb), effectively no change. Percentage body fat fell most in the exercise-plus-diet creatine arm, by 3.24 points (95% CI −4.1 to −2.4), significantly more than the other three arms. Strength moved in the same direction: leg-press and bench-press one-repetition maxima showed group-by-time interactions favoring creatine (p=0.001 and p=0.003), and the no-exercise creatine group beat its placebo counterpart on bench press. The overall body-composition group-by-time interaction was p=0.037, a medium effect (partial eta-squared 0.073); bone mineral measures showed no significant effects.

The limits that reshape the headline

Three limits matter more than the point estimate. First, the no-exercise number is imprecise: its confidence interval runs from 0.2 kg to 2.0 kg (about 0.4 lb to 4.4 lb), close to no effect at the low end. A 1.1 kg point estimate from a 26-person stratum inside a 64-person trial indicates a direction more than a fixed size. Second, exercise status was self-selected. People who chose to exercise may differ from those who did not in ways randomization never balanced, so “even without exercise” describes a randomized contrast but borrows authority from a factor the trial did not randomize. Third, DXA “lean tissue” is a surrogate for muscle: the trial measured lean mass, not contractile muscle, and did not test whether any gain persisted. The cognitive and blood-marker results that favored creatine were prespecified as exploratory, not separately powered, and not adjusted for multiple comparisons — signals to follow up, not established benefits. Repeated cognitive testing can leave practice effects the design cannot fully exclude, and creatinine-based eGFR is confounded by creatine intake and muscle mass, with no cystatin C or measured GFR available.

Funding, conflicts and registration

The trial was funded by an unrestricted gift to the Texas A&M Foundation from the WoodNext Foundation. The creatine was supplied by AlzChem Group, a creatine manufacturer, which also funded the homocysteine assays. The senior author, Richard B. Kreider, has conducted industry-sponsored creatine research and holds several creatine-industry roles, including chair of the Scientific Advisory Board for AlzChem and advisory-board seats for Oath Nutrition and Trace Minerals; he is a co-founder of the International Society of Sports Nutrition. The other authors declared no conflicts of interest. None of this makes the result wrong, but a supplement maker supplying the product and paying for assays, with a senior author who advises that maker, is a reason to weigh a single trial with care. The trial was also registered retrospectively: its ISRCTN record (ISRCTN83081058) was submitted on 2025-04-11 and posted on 2025-06-11, after the first participant enrolled on 2024-07-10, so the registry cannot confirm that the outcomes were specified before the data were collected.

Where this sits

Creatine’s effect on lean mass with training is not seriously in dispute. A 2025 dose-response meta-analysis found creatine increased fat-free mass even without any diet intervention, in trained (1.82 kg) and untrained (1.23 kg) populations; the 2017 International Society of Sports Nutrition position stand frames its efficacy and safety; and a companion 2025 review addresses common creatine questions. A 2023 meta-analysis examined creatine plus resistance exercise and fat mass. What this trial adds is a randomized, double-blind, DXA-measured contrast in a middle-aged and older sedentary population, tested with and without a diet-and-exercise program. What it leaves open is the size and durability of the no-exercise effect, which it sizes modestly, with wide uncertainty and a self-selected exercise comparison. Nothing here is a recommendation to start, stop or change any supplement or training program.

Terms explained

  • Creatine monohydrate (CrM): the most common supplemental form of creatine, a compound involved in short bursts of cellular energy. In this trial it was taken as 10 g/day, split into two 5 g doses.
  • Double-blind, placebo-controlled randomized trial: participants are assigned to the treatment or to an inactive comparator (here, maltodextrin) by chance, and neither the participants nor the researchers assessing them know who is in which group, which limits several forms of bias.
  • Self-selected stratum: a subgroup formed because participants chose that condition rather than being assigned to it by chance. Here, people chose whether to take part in the exercise-and-diet program, so that grouping is not randomized.
  • DXA lean tissue mass (fat-free mass): an estimate, from dual-energy X-ray absorptiometry, of everything in the body that is not fat — muscle, bone, organs and water. It is a surrogate for muscle, not a direct measure of muscle tissue.
  • Exploratory endpoint: an outcome measured and reported without being prespecified as a powered, confirmatory question. Exploratory results can suggest what to test next, but they cannot on their own establish an effect.

Sources

  1. Primary source: Chun J, Liu Y, Kibler GL, Lee H, Babakhani K, Rhoades N, Bivins I, Ko J, Dickerson B, Gonzalez DE, Sowinski RJ, Rasmussen CJ, Kreider RB. “Effects of creatine supplementation with and without exercise and diet intervention on body composition, cognitive function, and markers of health in middle-aged and older adults.” 2026;23(sup1):2716273, published 2026-08-21 (online 2026-08-11). DOI: 10.1080/15502783.2026.2716273 · PMID: 42578920 · PMCID: PMC13463452. Peer-reviewed randomized controlled trial; registered as ISRCTN83081058; open access (CC-BY-NC). Full text read; supplementary Table S6 and Figure 4 not read.
  2. Press signal (discovery and framing only, not evidence): “Creatine may help build muscle even without exercise, study suggests.” Medical News Today, 2026-10-05. https://www.medicalnewstoday.com/articles/creatine-may-help-build-muscle-even-without-exercise-study
  3. Landscape — dose-response meta-analysis: Ashtary-Larky D, Mohammadi S, Hajizadeh L, et al. “Creatine supplementation and resistance training: a comparison between novice and experienced lifters — a systematic review and dose-response meta-analysis.” J Int Soc Sports Nutr 2025;22(sup1):2586523. DOI: 10.1080/15502783.2025.2586523 · PMID: 41433021 (abstract-level access).
  4. Landscape — creatine questions and misconceptions: “Part II. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?” J Int Soc Sports Nutr 2025. DOI: 10.1080/15502783.2024.2441760 · PMID: 39720835 (abstract-level access).
  5. Landscape — position stand: Kreider RB, Kalman DS, Antonio J, et al. “International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.” J Int Soc Sports Nutr 2017;14:18. DOI: 10.1186/s12970-017-0173-z · PMID: 28615996 (abstract-level access; co-authored by the senior author of the trial).
  6. Landscape — creatine plus resistance exercise and fat mass: Candow DG, Prokopidis K, Forbes SC, et al. “Resistance Exercise and Creatine Supplementation on Fat Mass in Adults <50 Years of Age: A Systematic Review and Meta-Analysis.” Nutrients 2023;15(20):4343. DOI: 10.3390/nu15204343 · PMID: 37892421 (abstract-level access).

Related Articles